Your browser doesn't support javascript.
loading
Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study.
Lee, Byung Wan; Ahn, Kyu Jeung; Cho, Ho Chan; Lee, Eun Young; Min, KyungWan; Dahaoui, Amine; Jeong, Jin Sook; Lim, Hyo Jin; Jang, Hak Chul.
Afiliação
  • Lee BW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Ahn KJ; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.
  • Cho HC; Department of Clinical Endocrinology, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
  • Lee EY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Min K; Department of Endocrinology and Metabolism, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Republic of Korea.
  • Dahaoui A; Novo Nordisk Pharma Korea Limited, Seoul, Republic of Korea.
  • Jeong JS; Novo Nordisk Pharma Korea Limited, Seoul, Republic of Korea.
  • Lim HJ; Novo Nordisk Pharma Korea Limited, Seoul, Republic of Korea.
  • Jang HC; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. janghak@snu.ac.kr.
Diabetes Ther ; 14(10): 1659-1672, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37468685

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article